New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy.Read More.
A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection.Read More.
The biliary microbiome – the collection of bacteria present in the bile ducts – was altered in patients who received neoadjuvant therapy prior to undergoing surgery for pancreatic cancer.Read More.
A study led by researchers at RCSI’s Department of Chemistry has the potential to help surgeons more accurately remove tumours and detect cancer in lymph nodes during surgery.Read More.
Researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies.Read More.
Researchers have discovered a way to improve immune-based treatments, such as adoptive T-cell therapy (ACT) and haematopoietic stem cell transplantation (HSCT), by modulating T-cells with thioredoxin, a powerful, naturally occurring antioxidant molecule.Read More.
The Researchers from HSE University (The Higher School of Economics) have used machine learning to discover that the two most widespread DNA structures – stem-loops and quadruplexes – cause genome mutations that lead to cancer.Read More.
A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.Read More.
The London Clinic now offers a new cutting-edge treatment called CAR-T cell therapy to adults with diffuse large B-cell lymphoma, where the patient’s immune cells are genetically modified to destroy their cancer cells.Read More.